Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial.
Vermersch P, Oreja-Guevara C, Siva A, Van Wijmeersch B, Wiendl H, Wuerfel J, Buffels R, Kadner K, Kuenzel T, Comi G; CASTING Investigators. Vermersch P, et al. Among authors: siva a. Eur J Neurol. 2022 Mar;29(3):790-801. doi: 10.1111/ene.15171. Epub 2021 Nov 25. Eur J Neurol. 2022. PMID: 34748672 Free PMC article. Clinical Trial.
Hepatitis B vaccine related-myelitis?
Karaali-Savrun F, Altintaş A, Saip S, Siva A. Karaali-Savrun F, et al. Among authors: siva a. Eur J Neurol. 2001 Nov;8(6):711-5. doi: 10.1046/j.1468-1331.2001.00290.x. Eur J Neurol. 2001. PMID: 11784358
Fatigue and sleep disturbance in multiple sclerosis.
Kaynak H, Altintaş A, Kaynak D, Uyanik O, Saip S, Ağaoğlu J, Onder G, Siva A. Kaynak H, et al. Among authors: siva a. Eur J Neurol. 2006 Dec;13(12):1333-9. doi: 10.1111/j.1468-1331.2006.01499.x. Eur J Neurol. 2006. PMID: 17116216
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O'Neill GN; BG-12 Phase IIb Study Investigators. Kappos L, et al. Lancet. 2008 Oct 25;372(9648):1463-72. doi: 10.1016/S0140-6736(08)61619-0. Lancet. 2008. PMID: 18970976 Clinical Trial.
Clinical characteristics of pediatric-onset neuro-Behçet disease.
Uluduz D, Kürtüncü M, Yapıcı Z, Seyahi E, Kasapçopur Ö, Özdoğan H, Saip S, Akman-Demir G, Siva A. Uluduz D, et al. Among authors: siva a. Neurology. 2011 Nov 22;77(21):1900-5. doi: 10.1212/WNL.0b013e318238edeb. Epub 2011 Nov 9. Neurology. 2011. PMID: 22076549
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Olsson T, Achiron A, Alfredsson L, Berger T, Brassat D, Chan A, Comi G, Eraksoy M, Hegen H, Hillert J, Jensen PE, Moiola L, Myhr KM, Oturai A, Schippling S, Siva A, Sorensen PS, Trampe AK, Weber T, Potts J, Plavina T, Paes D, Subramanyam M, Wiendl H, Dib H, Uren D, Hemmer B, Buck D. Olsson T, et al. Among authors: siva a. Mult Scler. 2013 Oct;19(11):1533-8. doi: 10.1177/1352458513477925. Epub 2013 Mar 4. Mult Scler. 2013. PMID: 23459571
282 results